GoodRx Holdings Inc
GDRX2.710USD
+0.090+3.44%
Close 11/21, 16:00（ET）Quotes delayed by 15 min
924.58MMarket Cap
29.12P/E TTM
More Details of GoodRx Holdings Inc Company
GoodRx Holdings, Inc. provides a consumer-focused digital healthcare platform in the United States. It offer consumers free access to transparent and lower prices for generic and brand medications, as well as comprehensive healthcare research and information. It also equips healthcare professionals to find and prescribe affordable medications. It offers information and tools to help consumers compare prices and save on their prescription drug purchases. It operates a price comparison platform that provides consumers with geographically relevant prescription pricing and provides access to negotiated prices through its codes that can be used to save money on prescriptions across the United States (the prescription transactions offering). It also offers other healthcare products and services, including pharmaceutical manufacturer solutions, subscriptions, and telehealth services. Its subscription offerings provide additional benefits to consumers of its prescription transactions offering.
GoodRx Holdings Inc Info
Ticker SymbolGDRX
Company nameGoodRx Holdings Inc
IPO dateSep 23, 2020
CEOMs. Wendy Lynn Barnes
Number of employees738
Security typeOrdinary Share
Fiscal year-endSep 23
Address2701 Olympic Boulevard
CitySANTA MONICA
Stock exchangeNASDAQ Global Select Consolidated
CountryUnited States of America
Postal code90404
Phone18552682822
Websitehttps://investors.goodrx.com/
Ticker SymbolGDRX
IPO dateSep 23, 2020
CEOMs. Wendy Lynn Barnes
Company Executives of GoodRx Holdings Inc
Name
Name/Position
Position
Shareholding
Change
Mr. Douglas Joseph (Doug) Hirsch
Mr. Douglas Joseph (Doug) Hirsch
Co-Founder, Director
Co-Founder, Director
5.49M
+0.37%
Mr. Trevor Bezdek
Mr. Trevor Bezdek
Non-Executive Co-Chairman of the Board
Non-Executive Co-Chairman of the Board
5.43M
+0.62%
Mr. Romin Nabiey
Mr. Romin Nabiey
Chief Accounting Officer
Chief Accounting Officer
156.49K
+7.72%
Mr. Ronald E. Bruehlman
Mr. Ronald E. Bruehlman
Independent Director
Independent Director
104.81K
+26.10%
Ms. Agnes Rey-Giraud
Ms. Agnes Rey-Giraud
Independent Director
Independent Director
82.98K
-47.55%
Ms. Kelly J. Kennedy
Ms. Kelly J. Kennedy
Independent Director
Independent Director
80.20K
+246.44%
Mr. Scott W. Wagner
Mr. Scott W. Wagner
Co-Chairman of the Board
Co-Chairman of the Board
--
--
Ms. Wendy Lynn Barnes
Ms. Wendy Lynn Barnes
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
--
--
Mr. Ian T. Clark
Mr. Ian T. Clark
Independent Director
Independent Director
--
--
Mr. Gregory K. Mondre
Mr. Gregory K. Mondre
Independent Director
Independent Director
--
--
View more
Name
Name/Position
Position
Shareholding
Change
Mr. Douglas Joseph (Doug) Hirsch
Mr. Douglas Joseph (Doug) Hirsch
Co-Founder, Director
Co-Founder, Director
5.49M
+0.37%
Mr. Trevor Bezdek
Mr. Trevor Bezdek
Non-Executive Co-Chairman of the Board
Non-Executive Co-Chairman of the Board
5.43M
+0.62%
Mr. Romin Nabiey
Mr. Romin Nabiey
Chief Accounting Officer
Chief Accounting Officer
156.49K
+7.72%
Mr. Ronald E. Bruehlman
Mr. Ronald E. Bruehlman
Independent Director
Independent Director
104.81K
+26.10%
Ms. Agnes Rey-Giraud
Ms. Agnes Rey-Giraud
Independent Director
Independent Director
82.98K
-47.55%
Ms. Kelly J. Kennedy
Ms. Kelly J. Kennedy
Independent Director
Independent Director
80.20K
+246.44%
Revenue Breakdown
FY2024
FY2023
FY2022
Relevant data have not been disclosed by the company yet.
By RegionUSD
Name
Revenue
Proportion
United States
792.32M
0.00%
By Business
By Region
Relevant data have not been disclosed by the company yet.
Shareholding Stats
Updated: Sun, Nov 16
Updated: Sun, Nov 16
Shareholders
Shareholder Types
Shareholders
Shareholders
Proportion
The Vanguard Group, Inc.
8.71%
Hirsch (Douglas Joseph)
5.21%
Bezdek (Trevor)
5.14%
Columbia Threadneedle Investments (US)
3.68%
Silver Lake Partners
3.35%
Other
73.90%
Shareholders
Shareholders
Proportion
The Vanguard Group, Inc.
8.71%
Hirsch (Douglas Joseph)
5.21%
Bezdek (Trevor)
5.14%
Columbia Threadneedle Investments (US)
3.68%
Silver Lake Partners
3.35%
Other
73.90%
Shareholder Types
Shareholders
Proportion
Investment Advisor
18.46%
Investment Advisor/Hedge Fund
16.84%
Individual Investor
11.93%
Hedge Fund
10.45%
Private Equity
4.28%
Research Firm
2.20%
Venture Capital
1.57%
Pension Fund
0.79%
Bank and Trust
0.43%
Other
33.05%
Institutional Shareholding
Updated: Wed, Oct 1
Updated: Wed, Oct 1
Reporting Period
No. of institutions
Shares Held
Proportion
Change
2025Q3
418
65.92M
62.62%
-28.30M
2025Q2
414
76.10M
77.19%
-26.12M
2025Q1
430
76.08M
75.38%
-27.61M
2024Q4
425
80.83M
75.88%
-18.32M
2024Q3
423
86.06M
87.09%
-8.88M
2024Q2
414
75.09M
79.37%
-19.17M
2024Q1
423
71.20M
76.21%
-26.93M
2023Q4
466
68.97M
74.51%
-38.48M
2023Q3
499
60.99M
72.58%
-34.21M
2023Q2
511
56.89M
68.47%
-40.37M
View more
Shareholder Activity
Name
Shares Held
Proportion
Change
Chg %
Date
The Vanguard Group, Inc.
8.55M
8.67%
-65.37K
-0.76%
Jun 30, 2025
Hirsch (Douglas Joseph)
5.47M
5.55%
+57.05K
+1.05%
Jun 03, 2025
Bezdek (Trevor)
5.39M
5.47%
--
--
Apr 09, 2025
Columbia Threadneedle Investments (US)
4.82M
4.89%
+184.73K
+3.99%
Jun 30, 2025
Silver Lake Partners
3.53M
3.58%
--
--
Jun 30, 2025
Renaissance Technologies LLC
3.60M
3.65%
+587.40K
+19.51%
Jun 30, 2025
Perot Investments
3.10M
3.14%
-68.46K
-2.16%
Jun 30, 2025
Dimensional Fund Advisors, L.P.
2.50M
2.53%
+204.01K
+8.89%
Jun 30, 2025
BlackRock Institutional Trust Company, N.A.
1.53M
1.56%
-52.07K
-3.28%
Jun 30, 2025
View more
Related ETFs
Updated: Thu, Nov 6
Updated: Thu, Nov 6
Name
Proportion
Fidelity Digital Health ETF
0.87%
Hypatia Women CEO ETF
0.48%
VictoryShares Small Cap Free Cash Flow ETF
0.27%
SPDR S&P Kensho New Economies Composite ETF
0.15%
WisdomTree US SmallCap Fund
0.1%
Pacer US Small Cap Cash Cows ETF
0.09%
Motley Fool Next Index ETF
0.08%
iShares U.S. Healthcare Providers ETF
0.06%
Strive Small-Cap ETF
0.02%
Invesco RAFI US 1500 Small-Mid ETF
0.02%
View more
Fidelity Digital Health ETF
Proportion0.87%
Hypatia Women CEO ETF
Proportion0.48%
VictoryShares Small Cap Free Cash Flow ETF
Proportion0.27%
SPDR S&P Kensho New Economies Composite ETF
Proportion0.15%
WisdomTree US SmallCap Fund
Proportion0.1%
Pacer US Small Cap Cash Cows ETF
Proportion0.09%
Motley Fool Next Index ETF
Proportion0.08%
iShares U.S. Healthcare Providers ETF
Proportion0.06%
Strive Small-Cap ETF
Proportion0.02%
Invesco RAFI US 1500 Small-Mid ETF
Proportion0.02%
Dividend
A total of
0.00
USD has been distributed in dividends over the past 5 years.
Date
Dividend
Record Date
Payment Date
Ex-dividend Date
No Data
Stock Split
Date
Type
Ratio
No Data
Date
Type
Ratio
No Data
FAQs
Who are the top five shareholders of GoodRx Holdings Inc?
The top five shareholders of GoodRx Holdings Inc are:
The Vanguard Group, Inc. holds 8.55M shares, accounting for 8.67% of the total shares.
Hirsch (Douglas Joseph) holds 5.47M shares, accounting for 5.55% of the total shares.
Bezdek (Trevor) holds 5.39M shares, accounting for 5.47% of the total shares.
Columbia Threadneedle Investments (US) holds 4.82M shares, accounting for 4.89% of the total shares.
Silver Lake Partners holds 3.53M shares, accounting for 3.58% of the total shares.
The Vanguard Group, Inc. holds 8.55M shares, accounting for 8.67% of the total shares.
Hirsch (Douglas Joseph) holds 5.47M shares, accounting for 5.55% of the total shares.
Bezdek (Trevor) holds 5.39M shares, accounting for 5.47% of the total shares.
Columbia Threadneedle Investments (US) holds 4.82M shares, accounting for 4.89% of the total shares.
Silver Lake Partners holds 3.53M shares, accounting for 3.58% of the total shares.
What are the top three shareholder types of GoodRx Holdings Inc?
The top three shareholder types of GoodRx Holdings Inc are:
The Vanguard Group, Inc.
Hirsch (Douglas Joseph)
Bezdek (Trevor)
The Vanguard Group, Inc.
Hirsch (Douglas Joseph)
Bezdek (Trevor)
How many institutions hold shares of GoodRx Holdings Inc (GDRX)?
As of 2025Q3, 418 institutions hold shares of GoodRx Holdings Inc, with a combined market value of approximately 65.92M, accounting for 62.62% of the total shares. Compared to 2025Q2, institutional shareholding has increased by -14.57%.
What is the biggest source of revenue for GoodRx Holdings Inc?
In FY2024, the -- business generated the highest revenue for GoodRx Holdings Inc, amounting to -- and accounting for --% of total revenue.
